Solbinsiran for severe high triglycerides
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called solbinsiran (LY3561774) for people with very high triglyceride levels. It aims to see if it can lower these fats in your blood and reduce the risk of pancreatitis or heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had very high triglyceride levels (≥500 mg/dL) in the past and again at two separate tests during screening.
- Your body mass index (BMI) must be between 18.5 and 45.0.
- You cannot have had a major heart attack, stroke, or similar event in the last 3 months.
- You cannot have a known genetic condition called Familial Chylomicronemia Syndrome.
- You cannot have a history of heavy alcohol abuse in the last 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called DR10624 to see if it can lower very high levels of triglycerides (a type of fat in the blood) in people who have not been helped enough by standard treatments. The study compares the new drug to a placebo (a dummy shot) over several months.
This study tests an investigational drug called plozasiran for people with severely high triglycerides that have already caused pancreatitis (inflammation of the pancreas). The goal is to see if the drug can lower triglycerides and help prevent future attacks.
This trial tests a new medicine called ION775 to help lower very high triglyceride levels in the blood. Triglycerides are a type of fat, and having too much can increase heart disease risk. The study will check if ION775 is safe and actually works when added to your regular cholesterol medications.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
This trial tests a new medicine called plozasiran that may lower very high triglyceride levels, which can reduce the risk of pancreatitis. It is for people with severe hypertriglyceridemia or a rare genetic condition called FCS.
This trial tests a new one-time gene-editing treatment (CS-121) for people with very high triglycerides that don't lower enough with standard medicines. The treatment aims to reduce triglycerides and could help prevent pancreatitis and heart problems, but it is an early-stage gene therapy with strict safety requirements.
Hear when a new Severe Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.